In a recent post, I mentioned that I wanted to build some tools for a stripped-down Linux running on a 3D printer with a MIPS ...

Authorities confirm deaths, say 66 injured Authorities say a 'technical accident' caused explosion Blast occurred during restart at Barzan gas supply facility DOHA, June 22 (Reuters) - Thirteen people ...

Browse projects, edit plans, run simulations, load flood results, extract flow hydrographs, and animate time steps — all inside QGIS, without opening HEC-RAS.

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

Boeing conducted testing for the MQ-28 Ghost Bat’s Radar Cross Section, validating its stealth performance. Boeing announced on June 1, 2026, that it has conducted Radar Cross Section (RCS) testing on ...

A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized Phase III RASolute 302 trial comparing daraxonrasib to ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...

Apple will add new Apple Intelligence photo editing tools to the Photos app in iOS 27, iPadOS 27, and macOS 27, reports Bloomberg. On-device ‌Apple Intelligence‌ will be able to make subtle changes to ...

After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step into the red-hot cancer field. The Chicago pharma has agreed to ...